Related Experiment Videos
Hypogonadism and androgen replacement therapy in elderly men
1Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
The American Journal of Medicine
|May 10, 2001
Summary
Testosterone therapy in hypogonadal elderly men improves bone density, body composition, and muscle strength. Discuss individual risks and benefits before initiating treatment for age-related testosterone decline.
Area of Science:
- Endocrinology
- Geriatrics
- Men's Health
Background:
- Testosterone levels naturally decline with age due to central and peripheral factors.
- Increased sex-hormone-binding globulin exacerbates the reduction in free testosterone in aging men.
Purpose of the Study:
- To review testosterone replacement therapy trials in elderly men.
- To outline a diagnostic approach for hypogonadal elderly men.
Main Methods:
- Review of recent long-term studies on testosterone therapy in hypogonadal elderly men.
- Analysis of diagnostic criteria and screening for hypogonadism in older men.
Main Results:
- Testosterone therapy demonstrated benefits in bone density, body composition, and muscle strength.
- No significant adverse effects on lipids or prostate were observed in studies.
- Initial screening involves total testosterone levels; free or bioavailable testosterone may be assessed if symptomatic with normal total levels.
Conclusions:
- Testosterone replacement therapy can be beneficial for hypogonadal elderly men.
- Individualized patient discussion regarding pros and cons is crucial for treatment decisions.
- A clear diagnostic pathway aids in managing age-related testosterone deficiency.